Cargando…
LBODP096 High Failure Rate Of Radioactive Iodine-131 (Rai) Therapy For The Treatment Of Grave's Disease And Toxic Multinodular Goiter In An Urban Municipal Hospital Clinic
BACKGROUND: Radioactive iodine-131 (RAI) therapy is used to treat hyperthyroidism secondary to toxic multinodular goiter (TMNG) and Graves’ Disease (GD). The treatment failure (TF) rate for RAI as reported in previous studies is 8-16% (1). Most patients respond to RAI with normalization of thyroid f...
Autores principales: | Handoo, Maryam Manzoor, Tahir, Marium, Shah, Jinal, Paliou, Maria, Trousdale, Rhonda Kay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625352/ http://dx.doi.org/10.1210/jendso/bvac150.1526 |
Ejemplares similares
-
ODP480 Failure to achieve remission post Radioactive iodine therapy
por: Paliou, Maria, et al.
Publicado: (2022) -
MON-579 Toxic Multinodular Goiter And Thyroid Cancer Risk
por: Kampe-Okotie, Doris, et al.
Publicado: (2019) -
PSAT345 Neonatal Graves (NG) Affecting 3 Newborns of a Mother Treated with Radioactive Iodine (RAI) for Graves’ Disease (GD)
por: Ali, Dalal S, et al.
Publicado: (2022) -
Thyroid Tuberculosis Causing Fever of Unknown Origin in a Patient With Multinodular Goiter
por: Rauf, Mohammad Talha, et al.
Publicado: (2021) -
MON-590 Outcomes Following Radioactive Iodine Therapy (RAI) in Hyperthyroid Patients with Grave’s Disease and Toxic Nodular Disease
por: Aljenaee, Khaled, et al.
Publicado: (2019)